<VariationArchive VariationID="2916178" VariationName="NM_032861.4(SERAC1):c.134_137del (p.Ser45fs)" VariationType="Deletion" Accession="VCV002916178" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3071687" VariationID="2916178">
      <GeneList>
        <Gene Symbol="SERAC1" FullName="serine active site containing 1" GeneID="84947" HGNC_ID="HGNC:21061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158109519" stop="158168262" display_start="158109519" display_stop="158168262" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158530535" stop="158589311" display_start="158530535" display_stop="158589311" Strand="-" />
          </Location>
          <OMIM>614725</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032861.4(SERAC1):c.134_137del (p.Ser45fs)</Name>
      <CanonicalSPDI>NC_000006.12:158150580:AAAGAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158150581" stop="158150584" display_start="158150581" display_stop="158150584" variantLength="4" positionVCF="158150580" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158571613" stop="158571616" display_start="158571613" display_stop="158571616" variantLength="4" positionVCF="158571612" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S45fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.158571615_158571618del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.158571615_158571618del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.158150583_158150586del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.158150583_158150586del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032889.1" sequenceAccession="NG_032889" sequenceVersion="1" change="g.22697_22700del">
            <Expression>NG_032889.1:g.22697_22700del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.4" sequenceAccession="NM_032861" sequenceVersion="4" change="c.134_137del" MANESelect="true">
            <Expression>NM_032861.4:c.134_137del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116250.3" sequenceAccession="NP_116250" sequenceVersion="3" change="p.Ser45fs">
            <Expression>NP_116250.3:p.Ser45fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073096.2" sequenceAccession="NR_073096" sequenceVersion="2" change="n.258_261del">
            <Expression>NR_073096.2:n.258_261del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032861.4(SERAC1):c.134_137del (p.Ser45fs) AND 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" Accession="RCV003647183" Version="1">
        <ClassifiedConditionList TraitSetID="8743">
          <ClassifiedCondition DB="MedGen" ID="C4040739">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22683713</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8743" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17318" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">3-METHYLGLUTACONIC ACIDURIA, TYPE VI</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ElementValue>
                <XRef ID="MONDO:0013875" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEGDEL syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA6</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MEGDEL</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SERAC1 deficiency comprises MEGD(H)EL syndrome (3-methylglutaconic aciduria with deafness-dystonia, [hepatopathy], encephalopathy, and Leigh-like syndrome), juvenile-onset complicated hereditary spastic paraplegia (in 1 consanguineous family), and adult-onset generalized dystonia (in 1 adult male). MEGD(H)EL syndrome is characterized in neonates by hypoglycemia and a sepsis-like clinical picture for which no infectious agent can be found. During the first year of life feeding problems, failure to thrive, and/or truncal hypotonia become evident; many infants experience (transient) liver involvement ranging from undulating transaminases to prolonged hyperbilirubinemia and near-fatal liver failure. By age two years progressive deafness, dystonia, and spasticity prevent further psychomotor development and/or result in loss of acquired skills. Affected children are completely dependent on care for all activities of daily living; speech is absent.</Attribute>
                <XRef ID="NBK195853" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12963" />
                <XRef ID="12963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741715</ID>
                <ID Source="BookShelf">NBK195853</ID>
              </Citation>
              <XRef ID="352328" DB="Orphanet" />
              <XRef ID="C4040739" DB="MedGen" />
              <XRef ID="MONDO:0013875" DB="MONDO" />
              <XRef Type="MIM" ID="614739" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8340394" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="6485867|MedGen:C3553597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004552371" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22683713</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser45Tyrfs*10) in the SERAC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERAC1 are known to be pathogenic (PMID: 22683713). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SERAC1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.158571613_158571616del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8340394" TraitType="Disease" MappingType="XRef" MappingValue="C3553597" MappingRef="MedGen">
        <MedGen CUI="C4040739" Name="3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

